Abstract
Increasing burden of non-communicable diseases like diabetes and cardiovascular disorders has made the global health scenario more challenging. Dyslipidemia in diabetes is a compounding risk factor for cardiovascular diseases, but there is dearth of identifying appropriate signatures to address this issue. The protein, adiponectin, is actively involved in regulating glucose levels as well as fatty acid breakdown playing crucial role in dyslipidemia and vascular complications. To identify the underlying genetic and molecular profile of adiponectin metabolic pathway in diabetic dyslipidemia and to correlate it with known biochemical and oxidative stress parameters of T2DM, we performed a case–control study in a total 264 individuals belonging to three categories such as diabetes with dyslipidemia (n = 88), diabetes without dyslipidemia (n = 86) and normal healthy controls (n = 90). Expression of adiponectin (ADIPOQ) and its receptors (ADIPOR1 and ADIPOR2) were measured in visceral and subcutaneous adipose tissues. A significant downregulated expression of ADIPOQ and its receptors in adipose tissues and PBMCs were linked with diabetic dyslipidemic condition. A multiple linear regression followed by MDR analysis implicated the elevated plasma malondialdehyde and decreased adiponectin level to be correlated with diabetic dyslipidemia. More interestingly, two single nucleotide polymorphisms of ADIPOQ (rs2241766 and rs1501299) were genetically associated with the risk of developing dyslipidemia. Other important biochemical factors found to be increased in diabetic dyslipidemic conditions included plasma C-reactive protein and 4-hydroxynonenal adducts. Our results explore, a complex interplay of genetic and biochemical parameters in diabetic dyslipidemia which is significant from the perspective of risk stratification and novel therapeutic strategy development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anjana RM, Pradeepa R, Deepa M et al (2011) Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 54:3022–3027. https://doi.org/10.1007/s00125-011-2291-5
Ayala A, Munoz MF, Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https://doi.org/10.1155/2014/360438
Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89. https://doi.org/10.1016/S1043-2760(01)00524-0
Bonfanti G, Ceolin RB, Valcorte T et al (2011) delta-Aminolevulinate dehydratase activity in type 2 diabetic patients and its association with lipid profile and oxidative stress. Clin Biochem 44:1105–1109. https://doi.org/10.1016/j.clinbiochem.2011.06.980
Chang LC, Huang KC, Wu YW et al (2009) The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 108:353–366. https://doi.org/10.1016/S0929-6646(09)60079-6
Domingueti CP, Dusse LM, Carvalho M et al (2016) Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications 30:738–745. https://doi.org/10.1016/j.jdiacomp.2015.12.018
Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR et al (2015) Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag 11:55–70. https://doi.org/10.2147/VHRM.S48753
Esterbauer H, Eckl P, Ortner A (1990) Possible mutagens derived from lipids and lipid precursors. Mutat Res 238:223–233. https://doi.org/10.1016/0165-1110(90)90014-3
Ghoshal K, Bhattacharyya M (2015) Adiponectin: Probe of the molecular paradigm associating diabetes and obesity. World J Diabetes 6:151–166. https://doi.org/10.4239/wjd.v6.i1.151
Ghoshal K, Das S, Aich K et al (2016) A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia. Clin Chim Acta 458:144–153. https://doi.org/10.1016/j.cca.2016.05.006
Ghoshal K, Chakraborty S, Das C et al (2017) Dielectric properties of plasma membrane: A signature for dyslipidemia in diabetes mellitus. Arch Biochem Biophys 635:27–36. https://doi.org/10.1016/j.abb.2017.10.002
Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129:e28–e292. https://doi.org/10.1161/01.cir.0000441139.02102.80
Haploview (2003–2006) Broad Institute of MIT and Harvard. Retrieved from https://www.broadinstitute.org/haploview/haploview\.
Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11–18. https://doi.org/10.1111/j.1467-789X.2009.00623.x
Izadi V, Farabad E, Azadbakht L (2013) Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Prev Med 4:133–140
Kang ES, Magkos F, Kim BS et al (2012) Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients. J Clin Endocrinol Metab 97:E129-135. https://doi.org/10.1210/jc.2011-1796
Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556. https://doi.org/10.1210/jc.2004-0395
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. https://doi.org/10.1093/nar/16.3.1215
Mohan V, Sandeep S, Deepa R et al (2007) Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 125:217–230
MDR Package (2012) Stacey Winham. Retrieved from https://www.rdocumentation.org/packages/MDR/versions/1.2
Pileggi S, Barlera S, Nicolis E et al (2014) Association of ADIPOQ variants and heart failure in an Italian population. Ther Adv Cardiovasc Dis 8:89–96. https://doi.org/10.1177/1753944714531063
Reddy KS (2009) Regional case studies-India. Nestle Nutr Workshop Ser Pediatr Program 63: 15–24 https://doi.org/https://doi.org/10.1159/000209969
Robinson K, Prins J, Venkatesh B (2011) Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care 15:221. https://doi.org/10.1186/cc10021
Rondinone CM (2006) Adipocyte-derived hormones, cytokines, and mediators. Endocrine 29:81–90. https://doi.org/10.1385/ENDO:29:1:181
Ronti T, Lupattelli G, Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355–365. https://doi.org/10.1111/j.1365-2265.2006.02474.x
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14. https://doi.org/10.1016/j.diabres.2009.10.007
Siitonen N, Pulkkinen L, Lindstrom J et al (2011) Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovasc Diabetol 10:83. https://doi.org/10.1186/1475-2840-10-83
SNPStats (2006) Institut Català d'Oncologia. Retrieved from https://www.snpstats.net/start.htm.
Tangvarasittichai S (2015) Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6:456–480. https://doi.org/10.4239/wjd.v6.i3.456
Tiwari BK, Pandey KB, Abidi AB et al (2013) Markers of Oxidative Stress during Diabetes Mellitus. J Biomark 2013:378790. https://doi.org/10.1155/2013/378790
Tu Y, Yu Q, Fan G et al (2014) Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses. Mol Cell Endocrinol 396:1–9. https://doi.org/10.1016/j.mce.2014.08.006
Varghese JF, Patel R, Yadav UCS (2018) Novel Insights in the Metabolic Syndrome-induced Oxidative Stress and Inflammation-mediated Atherosclerosis. Curr Cardiol Rev 14:4–14. https://doi.org/10.2174/1573403X13666171009112250
VassarStats (1998–2020) Richard Lowry. Retrieved from http://vassarstats.net/.
Weber D, Milkovic L, Bennett SJ et al (2013) Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol 1:226–233. https://doi.org/10.1016/j.redox.2013.01.012
Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935. https://doi.org/10.1210/jcem.86.5.7463
Wongcharoen W, Sutthiwutthichai S, Gunaparn S et al (2017) Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study. BMC Cardiovasc Disord 17:10. https://doi.org/10.1186/s12872-016-0450-9
Wu Y, Ding Y, Tanaka Y et al (2014) Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 11:1185–1200. https://doi.org/10.7150/ijms.10001
Yamamoto S, Matsushita Y, Nakagawa T et al (2014) Circulating adiponectin levels and risk of type 2 diabetes in the Japanese. Nutr Diabetes 4:e130. https://doi.org/10.1038/nutd.2014.27
Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769. https://doi.org/10.1038/nature01705
Acknowledgements
We acknowledge CSIR and UGC MRP for providing research fellowship to Dr. Kakali Ghoshal and Ms. Tanima Chatterjee respectively. We are grateful to UGC MRP, RSSDI WB Chapter 2014, UGC-CAS (Phase-I&II), DST-FIST, ICZM, World Bank, Department of Biochemistry for providing the instrumental facilities, chemicals and consumables. We express our sincere gratitude to all the participants involved in this work.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Ethical Approval
The research program was approved by Calcutta University Biosafety and Ethics Committee.
Informed Consent
An informed consent for participation in the study was obtained from each individual participating in this study who contributed us with blood and tissue samples.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ghoshal, K., Chatterjee, T., Chowdhury, S. et al. Adiponectin Genetic Variant and Expression Coupled with Lipid Peroxidation Reveal New Signatures in Diabetic Dyslipidemia. Biochem Genet 59, 781–798 (2021). https://doi.org/10.1007/s10528-021-10030-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10030-5